Eli Lilly Licenses Inpharmatica's Admensa Interactive | GenomeWeb

NEW YORK, June 30 (GenomeWeb News) - Eli Lilly has licensed Inpharmatica's Admensa Interactive software platform, Inpharmatica said today.

Admensa Interactive is a suite of predictive models and decision tools for drug discovery.

Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.